Skip to main content

Table 4 Cox-proportional hazard models for major adverse event

From: Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis

 

HR

95% CI

p-value

Univariate

Age

1.000

0.981 – 1.019

0.992

Men

1.015

0.654 – 1.577

0.947

Body mass index

0.971

0.909 – 1.039

0.401

Current smoking

1.587

1.067 – 2.359

0.022

Hypertension

1.435

0.917 – 2.246

0.114

Diabetes mellitus

0.929

0.629 – 1.372

0.712

NSTEMI/STEMI at index PCI

1.170

0.727 – 1.884

0.518

LDL-C

1.009

1.002 – 1.015

0.008

Triglyceride

1.001

0.999 – 1.004

0.312

Uric acid

1.110

0.980 – 1.257

0.100

Creatinine clearance

0.997

0.989 – 1.006

0.494

LVEF

0.976

0.955 – 0.998

0.031

Previous 1st generation DES

1.204

0.824 – 1.758

0.338

Multivessel involvement

1.225

0.819 – 1.833

0.324

CTO lesion

0.784

0.364 – 1.689

0.534

ISR type (II, III, IV)

0.951

0.647 – 1.400

0.800

DCB (vs DES)

1.487

0.974 – 2.271

0.066

Multivariate

Current smoking

1.521

0.957 - 2.416

0.076

Hypertension

1.469

0.870 - 2.481

0.150

LDL-C

1.011

1.003 - 1.019

0.006

LVEF

0.972

0.948 - 0.996

0.022

DCB (vs DES)

1.475

0.912 - 2.386

0.113

  1. HR, hazard ratio; 95% CI, 95% confidence interval; NSTEMI, non-ST segment elevation myocardial infarction; STEMI, ST segment elevation myocardial infarction; LDL-C, low density lipoprotein cholesterol; LVEF, left ventricular ejection fraction; DES, drug-eluting stent; CTO, chronic total occlusion; ISR, in-stent restenosis; DCB, drug-coated balloon 
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us